Article Details
Retrieved on: 2025-01-13 20:45:53
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Arbutus Biopharma (ABUS) announced its 2025 corporate objectives and provided a financial update. The Company had cash, cash equivalents and inv.
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here